Your browser doesn't support javascript.
loading
The Mutographs biorepository: A unique genomic resource to study cancer around the world.
Perdomo, Sandra; Abedi-Ardekani, Behnoush; de Carvalho, Ana Carolina; Ferreiro-Iglesias, Aida; Gaborieau, Valérie; Cattiaux, Thomas; Renard, Hélène; Chopard, Priscilia; Carreira, Christine; Spanu, Andreea; Nikmanesh, Arash; Cardoso Penha, Ricardo Cortez; Antwi, Samuel O; Ashton-Prolla, Patricia; Canova, Cristina; Chitapanarux, Taned; Cox, Riley; Curado, Maria Paula; de Oliveira, José Carlos; Dzamalala, Charles; Fabianova, Elenora; Ferri, Lorenzo; Fitzgerald, Rebecca; Foretova, Lenka; Gallinger, Steven; Goldstein, Alisa M; Holcatova, Ivana; Huertas, Antonio; Janout, Vladimir; Jarmalaite, Sonata; Kaneva, Radka; Kowalski, Luiz Paulo; Kulis, Tomislav; Lagiou, Pagona; Lissowska, Jolanta; Malekzadeh, Reza; Mates, Dana; McCorrmack, Valerie; Menya, Diana; Mhatre, Sharayu; Mmbaga, Blandina Theophil; de Moricz, André; Nyirády, Péter; Ognjanovic, Miodrag; Papadopoulou, Kyriaki; Polesel, Jerry; Purdue, Mark P; Rascu, Stefan; Rebolho Batista, Lidia Maria; Reis, Rui Manuel.
Afiliação
  • Perdomo S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Abedi-Ardekani B; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • de Carvalho AC; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Ferreiro-Iglesias A; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Gaborieau V; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Cattiaux T; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Renard H; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Chopard P; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Carreira C; Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Spanu A; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Nikmanesh A; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Cardoso Penha RC; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Antwi SO; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Ashton-Prolla P; Experimental Research Center, Genomic Medicine Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Canova C; Unit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padova, Italy.
  • Chitapanarux T; Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Cox R; Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Curado MP; Department of Epidemiology, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • de Oliveira JC; Associação de Combate ao Câncer em Goiás Hospital Araújo Jorge Goiânia, Goiânia, Brazil.
  • Dzamalala C; University of Malawi College of Medicine, Blantyre, Malawi.
  • Fabianova E; Regional Authority of Public Health, Banská Bystrica, Slovakia.
  • Ferri L; Departments of Surgery and Oncology, McGill University, Montreal, QC, Canada.
  • Fitzgerald R; Early Cancer Institute, University of Cambridge, Cambridge, UK.
  • Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Gallinger S; Mount Sinai Hospital; Ontario Institute for Cancer Research (OICR), Toronto, ON, Canada.
  • Goldstein AM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
  • Holcatova I; Institute of Public Health & Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Huertas A; National Cancer Institute, Bogotá, Colombia.
  • Janout V; Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
  • Jarmalaite S; Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania; Department of Botany and Genetics, Institute of Biosciences, Vilnius University, Vilnius, Lithuania.
  • Kaneva R; Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.
  • Kowalski LP; Department of Epidemiology, A.C. Camargo Cancer Center, São Paulo, Brazil; University of São Paulo Medical School, São Paulo, Brazil.
  • Kulis T; Department of Urology, University Hospital Center Zagreb, Zagreb, Croatia; University of Zagreb School of Medicine, Zagreb, Croatia.
  • Lagiou P; National and Kapodistrian University of Athens, Athens, Greece.
  • Lissowska J; The Maria Sklodowska-Cure National Research Institute of Oncology, Warsaw, Poland.
  • Malekzadeh R; Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Mates D; Occupational Health and Toxicology, National Center for Environmental Risk Monitoring, National Institute of Public Health, Bucharest, Romania.
  • McCorrmack V; Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Menya D; Moi University, School of Public Health, Eldoret, Kenya.
  • Mhatre S; Division of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Tata Memorial Centre, Mumbai, India.
  • Mmbaga BT; Department of Surgery, Santa Casa School of Medicine, São Paulo, Brazil.
  • de Moricz A; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre & Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Nyirády P; Semmelweis University, Budapest, Hungary.
  • Ognjanovic M; IOCPR- International Organization for Cancer Prevention and Research, Serbia, Belgrade.
  • Papadopoulou K; Hellenic Cooperative Oncology Group (HeCOG), Athens, Greece.
  • Polesel J; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Rascu S; Urology Department, "Carol Davila" University of Medicine and Pharmacy - "Prof. Dr. Th. Burghele" Clinical Hospital, Bucharest, Romania.
  • Rebolho Batista LM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil; Life and Health Sciences Research Institute (ICVS), School of Medicine, Minho University, Braga, Portugal.
Cell Genom ; 4(3): 100500, 2024 Mar 13.
Article em En | MEDLINE | ID: mdl-38325367
ABSTRACT
Large-scale biorepositories and databases are essential to generate equitable, effective, and sustainable advances in cancer prevention, early detection, cancer therapy, cancer care, and surveillance. The Mutographs project has created a large genomic dataset and biorepository of over 7,800 cancer cases from 30 countries across five continents with extensive demographic, lifestyle, environmental, and clinical information. Whole-genome sequencing is being finalized for over 4,000 cases, with the primary goal of understanding the causes of cancer at eight anatomic sites. Genomic, exposure, and clinical data will be publicly available through the International Cancer Genome Consortium Accelerating Research in Genomic Oncology platform. The Mutographs sample and metadata biorepository constitutes a legacy resource for new projects and collaborations aiming to increase our current research efforts in cancer genomic epidemiology globally.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França